Guselkumab Persistence in UC and Crohn's Disease, Saudi Arabia
Summary
NIH registered ClinicalTrials.gov Study NCT07541261, an observational real-world study evaluating treatment persistence of guselkumab in participants with moderate to severe Crohn's disease or ulcerative colitis in Saudi Arabia. The study has no listed interventions and is classified as observational. Conditions studied include Colitis, Ulcerative and Crohn Disease.
What changed
NIH registered a new observational clinical trial on ClinicalTrials.gov. Study NCT07541261 evaluates how long patients with moderate to severe Crohn's disease or ulcerative colitis continue taking guselkumab in a real-world setting in Saudi Arabia. No interventions are administered; the study observes treatment patterns. Healthcare providers and pharmaceutical companies conducting inflammatory bowel disease research should note this registry entry for awareness of ongoing real-world evidence studies in the MENA region.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
Observational NCT07541261 Kind: OBSERVATIONAL Apr 21, 2026
Abstract
The main purpose of this study is to evaluate treatment persistence of guselkumab (that is how long a person keeps taking their prescribed medicine or continues with their treatment plan without stopping) in participants with moderate to severe crohn's disease (CD) or ulcerative colitis (UC) in real-world setting. CD and UC are Inflammatory bowel disease, a group of inflammatory conditions of the colon and small intestine.
Conditions: Colitis, Ulcerative, Crohn Disease
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.